6185.HK
CANSINOBIO
HK$25.82
+1.41%
2026-05-29
About CANSINOBIO
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.
Key Fundamentals
P/E Ratio
198.62
Forward P/E
17.19
EPS (TTM)
HK$0.13
ROE
-0.0%
Revenue Growth (YoY)
38.7%
Profit Margin
-0.1%
Debt/Equity
23.59
Price/Book
1.13
Beta
1.16
Market Cap
HK$6.38B
Avg Volume (10D)
1.3M
Recent Breakout Signals
No recent breakout signals detected for 6185.HK.
Recent Price Range (60 Days)
60D High
HK$35.68
60D Low
HK$24.88
Avg Volume
991K
Latest Close
HK$25.82
Get breakout alerts for 6185.HK
Sign up for Breakout Scanner to receive daily notifications when 6185.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
CANSINOBIO (6185.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 6185.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 6185.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.